Latest1 information on COVID-19
©2022 Stanford Medicine
Recruiting
I'm InterestedTrial ID: NCT03824535
18F-FSPG PET/CT and Integrated Biomarkers for Early Lung Cancer Detection in Patients With Indeterminate Pulmonary Nodules
Clinical Professor, Radiology - Rad/Nuclear Medicine
Inclusion Criteria:
- Pulmonary nodule between the size of 7 to 30 mm. Subjects with multiple nodules may be
eligible if the dominant nodule is 7 to 30 mm
- Undergoing standard of care 18F-FDG PET imaging (for indeterminate pulmonary nodule)
- Current or former cigarette smoker, with >= 20 pack years
- Documented informed consent
Exclusion Criteria:
- History or previous diagnosis of lung cancer
- Cancer diagnosis within the last 5 years
- Pregnant or nursing
procedure: Computed Tomography
drug: Fludeoxyglucose F-18
drug: Fluorine F 18 L-glutamate Derivative BAY94-9392
procedure: Positron Emission Tomography
Recruiting
I'm Interested
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Mahima Goel
650-723-0371